Why the study?
Does the ATP-sensitive potassium channel blocker glyburide abolish the infarct size-reducing effects of ischemic preconditioning or adenosine A1-receptor activation in a canine model of myocardial ischemia?
Population
Anesthetized dogs subjected to 60 minutes of left circumflex coronary artery occlusion and 5 hours of…
Comparison
Glyburide administered 20 minutes before… vs Vehicle or sham preconditioning
Design
Preclinical
Follow-up
5 hours of reperfusion
Authors
Loading...
KATP channels mediate preconditioning cardioprotection in canines; leaves open translation to human ischemia management.
Does the ATP-sensitive potassium channel blocker glyburide abolish the infarct size-reducing effects of ischemic preconditioning or adenosine A1-receptor activation in a canine model of myocardial ischemia?
In a canine model, the cardioprotective effects of ischemic preconditioning and adenosine A1-receptor activation against myocardial infarction are mediated by ATP-sensitive potassium channels.
Grover et al. (1992) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: